Exploring The Nipah Virus: Insights Into Pathogenesis And Therapeutic Approaches

Authors

  • Divya V, Aparna V, Lakshmy M, Anu. K, Sunitha V. R Author

DOI:

https://doi.org/10.48047/acfxav57

Keywords:

Nipah virus, BSL-4 pathogen, Antiviral drugs, Vaccines, computational approaches, molecular targets

Abstract

Nipah virus (NiV), classified as a biosafety level-4 (BSL-4) pathogen, poses a significant challenge in the field of infectious diseases, as its capacity to move between animals and humans raises serious global health concerns. This analysis explores the historical progression of NiV outbreaks, examining its effects on communities globally. This study investigates the emergence and epidemiology of the virus, focussing on its transmission dynamics and the significant impact it has had on affected regions. The neurological sequelae observed in survivors highlight the critical need for thorough care strategies. The exploration of molecular 
targets for antiviral drug development and current vaccine initiatives is undertaken, in conjunction with computational strategies in drug design. Targeting Ephrin-B2 and Ephrin-B3 presents a promising approach in NiV therapeutics, providing specificity and the potential for broad-spectrum activity.  

Downloads

Download data is not yet available.

References

Harcourt, B. H. et al. Molecular characterization of Nipah virus, a newly emergent paramyxovirus. Virology 271, 334–349 (2000).

Yob, J. M. et al. Nipah virus infection in bats (order Chiroptera) in peninsular Malaysia. Emerg. Infect. Dis. 7, 439–441 (2001).

Harcourt, B. H. et al. Molecular characterization of the polymerase gene and genomic termini of Nipah virus. Virology 287, 192–201 (2001).

Downloads

Published

2024-12-10

How to Cite

Exploring The Nipah Virus: Insights Into Pathogenesis And Therapeutic Approaches (Divya V, Aparna V, Lakshmy M, Anu. K, Sunitha V. R , Trans.). (2024). Cuestiones De Fisioterapia, 53(03), 1678-1686. https://doi.org/10.48047/acfxav57